Monoclonal antibody therapies against SARS-CoV-2
Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely
used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs …
used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs …
Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence
Sterilizing immunity after vaccination is desirable to prevent the spread of infection from
vaccinees, which can be especially dangerous in hospital settings while managing frail …
vaccinees, which can be especially dangerous in hospital settings while managing frail …
Prophylaxis against covid-19: living systematic review and network meta-analysis
Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …
the previous version (available as a data supplement). When citing this paper please …
COVID-19 at a glance: An up-to-date overview on variants, drug design and therapies
D Iacopetta, J Ceramella, A Catalano, C Saturnino… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Polyclonal anti-whole cell IgY passive immunotherapy shields against P. aeruginosa-induced acute pneumonia and burn wound infections in murine models
Pseudomonas aeruginosa (PA) is a multidrug-resistant (MDR) opportunistic pathogen
causing severe hospital-, and community-acquired infections worldwide. Thus, the …
causing severe hospital-, and community-acquired infections worldwide. Thus, the …
Trends in industrialization and commercialization of IgY technology
S Yakhkeshi, R Wu, B Chelliappan… - Frontiers in …, 2022 - frontiersin.org
IgY technology refers to the strategic production process involved in generating avian
immunoglobulin (IgY) against target antigens in a much more cost-effective manner with …
immunoglobulin (IgY) against target antigens in a much more cost-effective manner with …
Egg yolk antibody for passive immunization: status, challenges, and prospects
The immunoglobulin Y (IgY) derived from hyperimmune egg yolk is a promising passive
immune agent to combat microbial infections in humans and livestock. Numerous studies …
immune agent to combat microbial infections in humans and livestock. Numerous studies …
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
Convalescent plasma has been extensively tested during the COVID-19 pandemic as a
transfusion product. Similarly, monoclonal antibodies have been largely administered either …
transfusion product. Similarly, monoclonal antibodies have been largely administered either …
Are hamsters a suitable model for evaluating the immunogenicity of RBD-based anti-COVID-19 subunit vaccines?
IA Merkuleva, DN Shcherbakov, MB Borgoyakova… - Viruses, 2022 - mdpi.com
Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are
considered one of the most effective weapons against COVID-19. During the first step of …
considered one of the most effective weapons against COVID-19. During the first step of …
[HTML][HTML] Passive immunization with anti-FimA egg yolk antibodies (IgYs) mitigate Acinetobacter baumannii pneumonia in mice
N Shaygankho, A Jahangiri, I Rasooli - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Acinetobacter baumannii is a formidable pathogen, characterized by high mortality rates and
pan-drug-resistant strains. Current commercial antibiotics lack efficacy against drug-resistant …
pan-drug-resistant strains. Current commercial antibiotics lack efficacy against drug-resistant …